Truepoint Inc’s Boston Scientific BSX Stock Holding History

Truepoint Inc’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,715	Closed	-$330K	–	136
2023 Q4	$330K	Buy	+5,715	New	+$305K	0.01%	157
2020 Q1	–	Sell	-5,387	Closed	-$244K	–	56
2019 Q4	$244K	Hold	5,387	–	–	0.02%	106
2019 Q3	$219K	Buy	5,387 +557	+12%	+$23.6K	0.02%	103
2019 Q2	$208K	Sell	4,830 -3,154	-40%	-$121K	0.02%	116
2019 Q1	$306K	Buy	7,984 +236	+3%	+$9.01K	0.03%	89
2018 Q4	$274K	Buy	+7,748	New	+$281K	0.03%	86

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Truepoint Inc's BSX Position: Q1 2024 in Review

Truepoint Inc sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 5,715 shares — an estimated $330K sold.

Truepoint Inc first reported a position in BSX in Q4 2018 and held it in 6 quarters. The position peaked at $330K in Q4 2023. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

Truepoint Inc reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
Truepoint Inc sold 5,715 Boston Scientific shares in Q1 2024, an estimated $330K.
Truepoint Inc first reported a position in Boston Scientific in Q4 2018 and held it in 6 quarters.
Truepoint Inc's Boston Scientific position peaked at $330K in Q4 2023.
1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Truepoint Inc's 13F filing for Q1 2024, filed 9 May 2024.